Arlo N. McGinn, Ph.D.

2013 Pharmacology and Toxicology University of Utah, Salt Lake City, UT 
Pharmacy, Pharmacology, Genetics
"Arlo McGinn"
Mean distance: 17.61 (cluster 19)


Sign in to add mentor
William  R. Crowley grad student 2013 University of Utah
 (Bioreducible polymer-mediated gene therapy for the treatment of ischemic heart disease.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Lee Y, McGinn AN, Olsen CD, et al. (2013) Human erythropoietin gene delivery for cardiac remodeling of myocardial infarction in rats. Journal of Controlled Release : Official Journal of the Controlled Release Society. 171: 24-32
Won YW, McGinn AN, Lee M, et al. (2013) Post-translational regulation of a hypoxia-responsive VEGF plasmid for the treatment of myocardial ischemia. Biomaterials. 34: 6229-38
Won YW, McGinn AN, Lee M, et al. (2013) Targeted gene delivery to ischemic myocardium by homing peptide-guided polymeric carrier. Molecular Pharmaceutics. 10: 378-85
McGinn AN, Nam HY, Ou M, et al. (2011) Bioreducible polymer-transfected skeletal myoblasts for VEGF delivery to acutely ischemic myocardium. Biomaterials. 32: 942-9
Nam HY, McGinn A, Kim PH, et al. (2010) Primary cardiomyocyte-targeted bioreducible polymer for efficient gene delivery to the myocardium. Biomaterials. 31: 8081-7
See more...